Pioneers in Oncology Care
Unmatched experience, unmatched access
For over 3 decades, Biologics has been at the forefront of working with biopharma partners to successfully bring oncology therapies to market.
Collaborating closely with clinical-stage manufacturers, our seasoned and dynamic specialty pharmacy team possesses an in-depth understanding of patient care essentials and market trends, ensuring every product launch is a success.
We work hand-in-hand with our biopharma partners to craft innovative and tailored solutions, devising launch strategies that are as unique as the therapies themselves and the populations they serve. Our goal is simple – we work together to achieve outstanding outcomes.
Rooted in clinical expertise with a personalized approach to patient care, our strategic solutions for your oral oncology drugs ensure ease of access, meaningful engagement and increased adherence.
At Biologics, patients are at the heart of our mission. We proactively track both expected and unforeseen national, regional and local events to craft comprehensive contingency strategies, ensuring that therapy delivery remains uninterrupted, mitigating the impact these crises have on patient care. Our commitment ensures that patients continue to adhere to their therapy plans.
A close, collaborative partnership, supporting the oncology commercialization process
As developing treatment options for oncology patients continues to be vital, biopharma companies must strategically partner with a specialty pharmacy capable of addressing the unique needs of the oncology population with agility.
The transition from clinical development to market access presents unique challenges in the oncology space. As biopharma companies shift from regulatory functions to commercial planning, leveraging the commercial expertise of their specialty pharmacy partners is essential for success. Support from by an experienced specialty pharmacy, like Biologics, is crucial for the market success of oncology drugs. A successful drug launch enables the company to address unmet patient needs effectively, positioning patients at the forefront of its oncology commercialization strategy. This strategic engagement, initiated during the early phases of commercial planning, is necessary for brand success in the competitive oncology
market. With the emergence of more therapies for previously unmet oncologic needs, companies aim for seamless commercialization paths alongside simplified treatment journeys for their patients.
We work collaboratively with our oncology biopharma partners by creating an ecosystem of services to enhance market access, optimize patient outcomes and streamline commercialization efforts. Our deep expertise in oncology ensures your drug has a leg-up when launching in the marketplace.
We tailor solutions to meet the needs of our partners by leveraging a deep bench of services including:
Business intelligence, data, analytics
Comprehensive insights and advanced analytical tools to enable partners to make informed, strategic decisions and streamline operations.
Clinical & expanded access protocols
Guidance through the regulatory landscape, crafting tailored protocols that align with clinical objectives and patient access requirements.
Cell & gene strategies
Unparalleled expertise and support to ensure the successful development and delivery of transformative treatments.
Therapy education & nursing support
Customized resources and expert guidance ensure that each patient fully understands their treatment journey at each step along the way.
Risk evaluation & mitigation strategies (REMS)
Access & adherence
Seamless integration and optimal access to increase therapeutic outcomes.
Patient assistance programs & copay solutions
Personalized support to ensure that every patient has access to the therapies they need.
Operational excellence & innovation
The Biologics difference
At Biologics, our commitment to delivering hyper-focused, personalized care empowers us to navigate the intricate landscape of the oncology industry. We understand the complexities faced by our patients and stakeholders alike, and with our clinical expertise in the specialty pharmacy sector, we stand as a steadfast partner. Supported by McKesson’s enterprise capabilities, we maintain our agility and independence, ensuring unwavering dedication to our biopharma partners while staying true to our core mission—prioritizing each patient and their unique therapeutic journey.
30 +
Years of expertise in the highly complex specialty pharmacy oncology space
77,000 +
patients supported by Biologics in 2024
200 +
total therapies
25 +
The exclusive specialty pharmacy for more than 25 life-changing
drugs
5
Preferred dispensing provider for 5 cell and gene therapies
40 +
1 of 3 or fewer specialty pharmacy provider (SPP) LDD contracts
10
integrated HUB programs
50 +
Robust licensing in all U.S. states and territories
Contact us to learn how we can support your oncology therapy launch.
Overview & Support Services
Highlights Biologics' capabilities in connecting therapies with the right prescribers and patients.
Real-World Impact
Evidence-based examples showing how Biologics improves patient access and outcomes.
Financial & Access Resources
Foundational materials to support your overall collaboration with Biologics.